Certified by Founder
Lodge
Pragma Bio
start up
United States
- South San Francisco, California
- 27/03/2023
- Unknown
- $10,000,000
Pragma Bio exists to find cures for undruggable immunological disorders. We use real-world data and synthetic biology to map out multi-omic signatures associated with clinical outcomes in order to produce microbial-derived small molecules with therapeutic potential.
- Industry Biotechnology
- Website https://www.pragmabio.com/
- LinkedIn https://www.linkedin.com/company/pragmabio/
NcodiN | $18,456,480 | (Nov 21, 2025)
Voio | $8,600,000 | (Nov 21, 2025)
Stuut | $29,500,000 | (Nov 21, 2025)
Made Card | $8,000,000 | (Nov 21, 2025)
Poly(US) | $8,000,000 | (Nov 21, 2025)
Runlayer | $11,000,000 | (Nov 21, 2025)
AI Proteins | $41,500,000 | (Nov 21, 2025)
Automat | $15,500,000 | (Nov 21, 2025)
EQORE | $1,700,000 | (Nov 21, 2025)
Poppy Flowers | $2,700,000 | (Nov 21, 2025)
WellBeam Inc | $10,000,000 | (Nov 21, 2025)
Revenium | $13,500,000 | (Nov 21, 2025)